These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 8162668)

  • 1. Pharmacokinetics of famciclovir in subjects with varying degrees of renal impairment.
    Boike SC; Pue MA; Freed MI; Audet PR; Fairless A; Ilson BE; Zariffa N; Jorkasky DK
    Clin Pharmacol Ther; 1994 Apr; 55(4):418-26. PubMed ID: 8162668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Linear pharmacokinetics of penciclovir following administration of single oral doses of famciclovir 125, 250, 500 and 750 mg to healthy volunteers.
    Pue MA; Pratt SK; Fairless AJ; Fowles S; Laroche J; Georgiou P; Prince W
    J Antimicrob Chemother; 1994 Jan; 33(1):119-27. PubMed ID: 8157552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of penciclovir in healthy cats following oral administration of famciclovir or intravenous infusion of penciclovir.
    Thomasy SM; Whittem T; Bales JL; Ferrone M; Stanley SD; Maggs DJ
    Am J Vet Res; 2012 Jul; 73(7):1092-9. PubMed ID: 22738064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of famciclovir in subjects with chronic hepatic disease.
    Boike SC; Pue M; Audet PR; Freed MI; Fairless A; Ilson BE; Zariffa N; Jorkasky DK
    J Clin Pharmacol; 1994 Dec; 34(12):1199-207. PubMed ID: 7738216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The clinical pharmacokinetics of famciclovir.
    Gill KS; Wood MJ
    Clin Pharmacokinet; 1996 Jul; 31(1):1-8. PubMed ID: 8827396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disposition of cefpodoxime proxetil in healthy volunteers and patients with impaired renal function.
    St Peter JV; Borin MT; Hughes GS; Kelloway JS; Shapiro BE; Halstenson CE
    Antimicrob Agents Chemother; 1992 Jan; 36(1):126-31. PubMed ID: 1590677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics and safety of penciclovir following oral administration of famciclovir to cats.
    Thomasy SM; Maggs DJ; Moulin NK; Stanley SD
    Am J Vet Res; 2007 Nov; 68(11):1252-8. PubMed ID: 17975982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of penciclovir after oral administration of its prodrug famciclovir to horses.
    Tsujimura K; Yamada M; Nagata S; Yamanaka T; Nemoto M; Kondo T; Kurosawa M; Matsumura T
    J Vet Med Sci; 2010 Mar; 72(3):357-61. PubMed ID: 19959884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of renal impairment on the pharmacokinetics of intravenous zanamivir.
    Cass LM; Efthymiopoulos C; Marsh J; Bye A
    Clin Pharmacokinet; 1999; 36 Suppl 1():13-9. PubMed ID: 10429836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of renal impairment on the pharmacokinetics and safety of fosfluconazole and fluconazole following a single intravenous bolus injection of fosfluconazole.
    Sobue S; Tan K; Layton G; Leclerc V; Weil A
    Br J Clin Pharmacol; 2004 Jun; 57(6):773-84. PubMed ID: 15151523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of age and renal and hepatic impairment on the pharmacokinetics of sildenafil.
    Muirhead GJ; Wilner K; Colburn W; Haug-Pihale G; Rouviex B
    Br J Clin Pharmacol; 2002; 53 Suppl 1(Suppl 1):21S-30S. PubMed ID: 11879256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimates of the pharmacokinetics of famciclovir and its active metabolite penciclovir in young Asian elephants (Elephas maximus).
    Brock AP; Isaza R; Hunter RP; Richman LK; Montali RJ; Schmitt DL; Koch DE; Lindsay WA
    Am J Vet Res; 2012 Dec; 73(12):1996-2000. PubMed ID: 23176429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disposition of minoxidil in patients with various degrees of renal function.
    Halstenson CE; Opsahl JA; Wright CE; Fleishaker JC; Andreadis NA; Sobieraj J; Matzke GR
    J Clin Pharmacol; 1989 Sep; 29(9):798-802. PubMed ID: 2808745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of sparfloxacin in patients with renal impairment.
    Dorr MB; Johnson RD; Jensen B; Magner D; Marbury T; Talbot GH
    Clin Ther; 1999 Jul; 21(7):1202-15. PubMed ID: 10463518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitreous penetration of orally administered famciclovir.
    Chong DY; Johnson MW; Huynh TH; Hall EF; Comer GM; Fish DN
    Am J Ophthalmol; 2009 Jul; 148(1):38-42.e1. PubMed ID: 19375688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of cefotaxime and its active metabolite in children with renal dysfunction.
    Paap CM; Nahata MC; Mentser MA; Mahan JD; Puri SK; Hubbard JW
    Antimicrob Agents Chemother; 1991 Sep; 35(9):1879-83. PubMed ID: 1952862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic and pharmacokinetic studies following oral administration of 14C-famciclovir to healthy subjects.
    Filer CW; Allen GD; Brown TA; Fowles SE; Hollis FJ; Mort EE; Prince WT; Ramji JV
    Xenobiotica; 1994 Apr; 24(4):357-68. PubMed ID: 8059539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical pharmacokinetics of gabapentin after administration of gabapentin enacarbil extended-release tablets in patients with varying degrees of renal function using data from an open-label, single-dose pharmacokinetic study.
    Lal R; Sukbuntherng J; Luo W; Chen D; Blumenthal R; Ho J; Cundy KC
    Clin Ther; 2012 Jan; 34(1):201-13. PubMed ID: 22206794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of renal impairment on the pharmacokinetics of PD 0200390, a novel ligand for the voltage-gated calcium channel alpha-2-delta subunit.
    Corrigan B; Feltner DE; Ouellet D; Werth JL; Moton AE; Gibson G
    Br J Clin Pharmacol; 2009 Aug; 68(2):174-80. PubMed ID: 19694735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of renal impairment on the pharmacokinetics of oxcarbazepine and its metabolites.
    Rouan MC; Lecaillon JB; Godbillon J; Menard F; Darragon T; Meyer P; Kourilsky O; Hillion D; Aldigier JC; Jungers P
    Eur J Clin Pharmacol; 1994; 47(2):161-7. PubMed ID: 7859804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.